Warfarin: all 179 studies that test it

Page 2 of 2. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult SubjectsCompletedNCT02461914Phase 1
• Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot StudyWithdrawnNCT02450682Phase 2
• A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy VolunteersStatus unknownNCT02426060Phase 1
• A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced TumorsCompletedNCT02422589Phase 1
• The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein ThrombosisStatus unknownNCT02398357Phase 4
• The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCTCompletedNCT02376803Phase 4
• Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated PatientsStatus unknownNCT02375646Not applicable
• Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and DigoxinWithdrawnNCT02345304Phase 1
• Effect of Opicapone at Steady State on Warfarin PharmacokineticsCompletedNCT02305030Phase 1
• Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male VolunteersCompletedNCT02256813Phase 1
• The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)CompletedNCT02254148Phase 1
• A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy SubjectsCompletedNCT02252731Phase 1
• Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal DisconnectionCompletedNCT02247414Phase 4
• Anticoagulation Regiments in Patients With Prosthetic Heart Valve ThrombosisStatus unknownNCT02240953Not applicable
• Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart ValvesStatus unknownNCT02240927Not applicable
• Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic SplenectomyStatus unknownNCT02238444Phase 4
• Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"CompletedNCT02206815Phase 4
• A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy SubjectsCompletedNCT02070510Phase 1
• Evaluation of Wound Drainage After Knee or Hip ArthroplastyWithdrawnNCT02054936Phase 4
• Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy SubjectsCompletedNCT02022254Phase 1
• Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in BrazilCompletedNCT02017197Phase 4
• Drug-drug Interaction Study(Lobeglitazone, Warfarin)CompletedNCT02002611Phase 1
• Cognitive Impairment Related to Atrial Fibrillation Prevention TrialCompletedNCT01994265Phase 4
• Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial FibrillationStatus unknownNCT01991951Not applicable
• Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin TherapyCompletedNCT01758640Phase 3
• Anticoagulation With Rivaroxaban in Cardioversion -The ARC StudyCompletedNCT01747746Phase 4
• Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.CompletedNCT01727453Phase 4
• Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney DiseaseWithdrawnNCT01668901Phase 4
• Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male SubjectsCompletedNCT01657825Phase 1
• Dexpramipexole and Warfarin Drug Drug Interaction (DDI) StudyCompletedNCT01597310Phase 1
• Warfarine in Unexplained OligohydramniosTerminatedNCT01569035Phase 4
• Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin TreatmentCompletedNCT01561937Phase 1
• LV Thrombus After Acute AMI: A Randomized Controlled TrialTerminatedNCT01556659Not applicable
• A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of WarfarinCompletedNCT01475279Phase 1
• The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial FibrillationCompletedNCT01438580Phase 4
• Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat MealsCompletedNCT01431690Phase 1
• A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedNCT01340846Phase 1
• A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological MalignanciesCompletedNCT01317927Phase 1
• BAY73-4506 Probe Substrate StudyCompletedNCT01287598Phase 1
• Optimal Duration of Anticoagulation in Deep Venous ThrombosisCompletedNCT01285661Phase 3
• A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of WarfarinWithdrawnNCT01214122Phase 1
• A Drug-Drug Interaction Study to Study the Effect of AZD1981 on WarfarinCompletedNCT01199341Phase 1
• A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult VolunteersCompletedNCT01195324Phase 1
• A Drug Interaction Study With Albiglutide and WarfarinCompletedNCT01147731Phase 1
• Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized TrialCompletedNCT01124058Phase 1
• Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter AblationCompletedNCT01006876Phase 3
• A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male VolunteersCompletedNCT00938132Phase 1
• Warfarin Patient Self-MonitoringCompletedNCT00925028Not applicable
• The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy SubjectsCompletedNCT00914667Phase 1
• Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy SubjectsCompletedNCT00904176Phase 1
• Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and WarfarinTerminatedNCT00870298Not applicable
• A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy SubjectsCompletedNCT00856570Phase 1
• Prophylaxis Against DVTs After Primary Hip and Knee Replacement SurgeryStatus unknownNCT00767559Not applicable
• Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.CompletedNCT00740883Phase 3
• Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)CompletedNCT00740493Phase 3
• Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance DoseStatus unknownNCT00700895Phase 3
• Patent Foramen Ovale in Cryptogenic Stroke StudyCompletedNCT00697151Phase 4
• Effect of Warfarin in the Treatment of Metachromatic LeukodystrophyCompletedNCT00683189Not applicable
• Warfarin After Anterior ST-Elevation Myocardial InfarctionCompletedNCT00662467Not applicable
• Absence of Residual Vein Thrombosis Permits to Withdrawn Oral AnticoagulantsCompletedNCT00623987Phase 4
• Duloxetine - Warfarin Pharmacodynamic StudyCompletedNCT00533026Phase 1
• Interaction Between ABT-335, Rosuvastatin and WarfarinCompletedNCT00487136Phase 1
• Modeling Genotype and Other Factors to Enhance the Safety of Coumadin PrescribingStatus unknownNCT00484640Not applicable
• Anticoagulant Therapy During Pacemaker ImplantationCompletedNCT00479362Phase 4
• Residual Vein Thrombosis Establishes the Optimal Duration of Oral AnticoagulantsCompletedNCT00438230Phase 4
• A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human VolunteersCompletedNCT00404274Phase 1
• Ultrasound Findings to Adjust the Duration of AnticoagulationCompletedNCT00380120Phase 3
• Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial DissectionWithdrawnNCT00265408Phase 1
• The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKORStatus unknownNCT00247702Not applicable
• Genetic Determinants of Warfarin Anticoagulation EffectStatus unknownNCT00162435Not applicable
• Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis CathetersCompletedNCT00157651Phase 3
• Warfarin and Antiplatelet Vascular EvaluationStatus unknownNCT00125671Phase 3
• Warfarin and Vatalanib in Treating Patients With Advanced Solid TumorsCompletedNCT00091299Phase 1
• Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous CathetersCompletedNCT00024297Not applicable
• Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate CancerCompletedNCT00014352Phase 2
• Aspirin Or Warfarin To Prevent StrokeTerminatedNCT00004728Phase 3
• Treatment for Blood Clots in the Veins of the LegsCompletedNCT00001713Phase 1
• Prevention of Recurrent Venous Thromboembolism (PREVENT)CompletedNCT00000614Phase 3
• Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)CompletedNCT00000517Phase 3

← Warfarin overview